US2009075253A1PendingUtilityA1

Bioreactive agents

Assignee: UNIV BOSTONPriority: May 11, 1994Filed: Dec 18, 2006Published: Mar 19, 2009
Est. expiryMay 11, 2014(expired)· nominal 20-yr term from priority
A61K 41/0042C07D 207/404C07K 1/13G01N 33/58C07D 311/16C07C 205/57G01N 33/532C07K 1/1077C12Q 1/6823C07D 495/04A61K 38/00G01N 33/5306C07H 21/00C07H 19/04C07C 205/45C07D 405/12C12P 21/00C12Q 1/6876
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to agents and conjugates that can be used to detect and isolate target components from complex mixtures such as nucleic acids from biological samples, cells from bodily fluids, and nascent proteins from translation reactions. Agents comprise a detectable moiety bound to a photoreactive moiety. Conjugates comprise agents coupled to substrates by covalent bounds which can be selectively cleaved with the administration of electromagnetic radiation. Targets substances labeled with detectable molecules can be easily identified and separated from a heterologous mixture of substances. Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered. Using photocleavable molecular precursors as the conjugates, label can be incorporated into macromolecules, the nascent macromolecules isolated and the label completely removed. The invention also relates to targets isolated with these conjugates which may be useful as pharmaceutical agents or compositions that can be administered to humans and other mammals. Useful compositions include biological agents such as nucleic acids, proteins, lipids and cytokines. Conjugates can also be used to monitor the pathway and half-life of pharmaceutical composition in vivo and for diagnostic, therapeutic and prophylactic purposes. The invention also relates to kits comprised of agents and conjugates that can be used for the detection of diseases, disorders and nearly any individual substance in a complex background of substances.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . A method, comprising:
 a) providing i) nucleic acid, ii) a conjugate, comprising a substrate covalently coupled to a detectable moiety through a cleavable linker, said substrate selected from the group consisting of nucleosides and nucleotides, said detectable moiety having the property of fluorescence, and iii) a polymerase; and   b) mixing said nucleic acid and said polymerase in the presence of said conjugate under conditions such that said conjugate is incorporated into said nucleic acid to produce labeled nucleic acid.   
     
     
         7 . The method of  claim 6 , wherein said nucleic acid is RNA. 
     
     
         8 . The method of  claim 6 , wherein said nucleic acid is DNA. 
     
     
         9 . The method of  claim 6 , wherein said detectable moiety is selected from the group consisting of rhodamines and fluoresceins. 
     
     
         10 . The method of  claim 6 , wherein said substrate is a nucleotide selected from the group consisting of NTP, dNTP and ddNTP

Join the waitlist — get patent alerts

Track US2009075253A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.